355121-64-1

Upstream product

• 355121-52-7 3,5-bis-allyloxy-4-bromo-benzaldehyde 
• 355121-63-0 4-[(S)-2-amino-3-(triisopropyl-silanoxy)-propyl]-phenol 
• 355121-59-4 (S)-2-allyloxycarbonylamino-3-(4-hydroxy-phenyl)-propionic acid methyl ester 
• 355121-58-3 (3,5-bis-allyloxy-4-bromo-phenyl)-methanol 
• 355121-61-8 [(S)-2-(4-allyloxy-phenyl)-1-hydroxymethyl-ethyl]-carbamic acid allyl ester 
• 355121-57-2 3,5-bis-allyloxy-4-bromo-benzoic acid allyl ester 
• 355121-60-7 (S)-2-allyloxycarbonylamino-3-(4-allyloxy-phenyl)-propionic acid methyl ester 
• 355121-62-9 [(S)-1-(4-allyloxy-phenyl)-2-(triisopropyl-silanyloxy)-ethyl]-carbamic acid allyl ester 
• 3417-91-2 L-tyrosine methyl ester HCl 

Downstream Products

• 355121-65-2 carbonic acid allyl ester 4-[(S)-2-[allyloxycarbonyl-(3,5-bis-allyloxy-4-bromo-benzyl)-amino]-3-(triisopropyl-silanyloxy)-propyl]-phenyl ester 
• 875488-53-2 (3,5-bisallyloxy-4-bromobenzyl)-[(S)-2-(4-hydroxyphenyl)-1-(triisopropylsilanyloxymethyl)ethyl]carbamic acid allyl ester 

Relevant academic research and scientific papers

Large scale synthesis of the Cdc42 inhibitor secramine A and its inhibition of cell spreading

We describe a large scale synthesis of secramine A. Consistent with its ability to inhibit activation of the small GTPase Cdc42, we find that secramine A inhibits cell spreading, a process previously shown to be Cdc42-dependent. The Royal Society of Chemistry 2006.